In recent months, Liverpool FC’s pursuit of Milos Kerkez has been one of the most talked-about transfer targets. With the Reds seeking a modern, energetic fullback to bolster their left side ...

Hungary left-back Milos Kerkez has departed his country's training camp for "private reasons" amid increased speculation surrounding a potential transfer move to Liverpool. Kerkez, 21, who ...

An air quality map shows conditions improving across the United States on Friday as smoke from the Canadian wildfires subsides after prompting air quality alerts and advisories in several states ...

Meanwhile, rumours persist about Bournemouth left-back Milos Kerkez, suggesting that the Reds are nearing another summer addition. Liverpool have already secured one promising Hungarian in the ...

Milos Kerkez's former club - AZ Alkmaar - have dropped a cryptic transfer hint as Liverpool attempt to complete a deal to sign the Hungary international. The Reds are aiming to finalise a swoop ...

Liverpool are ready to show their long-term commitment to Milos Kerkez, sources have told TEAMtalk, as we reveal the offer that the Premier League champions are ready to make to the Bournemouth ...

Hungary national team boss Marco Rossi has revealed Milos Kerkez will miss Friday's international friendly against Sweden as his transfer to Liverpool edges closer. The Bournemouth left-back had ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Milos Kerkez originally wanted to be a swimmer - now he's itching to make a splash at Liverpool following two remarkable seasons at Bournemouth. The tenacious Hungarian left-back's spectacular ...

You would forgive Andy Robertson for recoiling at the mere mention of the name Milos Kerkez. The 31-year-old's position as Liverpool's first-choice left-back - a post he has had a stranglehold on ...

Supernus has boosted its position in central nervous system therapies with a $400 million deal to acquire Adamas Pharma that will add two approved Parkinson's disease therapies to its stable.